Operating Margin of Keros Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Keros Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Keros Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2025 was 28%.
  • Keros Therapeutics, Inc. annual Operating Margin for 2025 was 28%.
  • Keros Therapeutics, Inc. annual Operating Margin for 2024 was -5939%, a 95% increase from 2023.
  • Keros Therapeutics, Inc. annual Operating Margin for 2023 was -112544%.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Keros Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 28% 01 Oct 2025 31 Dec 2025
Q3 2025 18% 01 Jul 2025 30 Sep 2025
Q2 2025 0.14% 01 Apr 2025 30 Jun 2025
Q1 2025 -4.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -5939% +106605% +95% 01 Oct 2024 31 Dec 2024
Q3 2024 -31342% 01 Jul 2024 30 Sep 2024
Q2 2024 -69615% 01 Apr 2024 30 Jun 2024
Q1 2024 -76733% 01 Jan 2024 31 Mar 2024
Q4 2023 -112544% 01 Oct 2023 31 Dec 2023
Q3 2020 -1444% 01 Jul 2020 30 Sep 2020
Q2 2020 -529% 01 Apr 2020 30 Jun 2020
Q1 2020 -243% 01 Jan 2020 31 Mar 2020
Q4 2019 -106% 01 Oct 2019 31 Dec 2019

Keros Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 28% 01 Jan 2025 31 Dec 2025
2024 -5939% +106605% +95% 01 Jan 2024 31 Dec 2024
2023 -112544% 01 Jan 2023 31 Dec 2023
2021 -280% 01 Jan 2021 31 Dec 2021
2019 -106% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.